Skip to main content
logo
Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
36.85
-0.55 (-1.47%)
At close: Aug 19, 2026, 4:00 PM EDT
37.30
+0.45 (1.22%)
Pre-market: Aug 20, 2026, 5:17 AM EDT

Cogent Biosciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
------
Revenue Growth
------
Gross Profit
------
Operating Income
-389.09-333.36-275.94-208.13-147.84-75.55
Net Income
-377.18-328.94-255.86-192.41-140.24-72.27
Earnings Per Share
-2.43-2.55-2.46-2.42-2.38-1.87
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
792.3900.77287.08273.17259.28219.68
Total Debt
244.26238.817.4718.8519.653.16
Net Cash (Debt)
548.04661.97269.61254.32239.63216.53
Net Cash Growth
209.30%145.53%6.01%6.13%10.67%-8.63%
Net Cash Per Share
3.535.132.593.194.075.59

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-307.55-264.44-207.79-153.62-118.64-58.76
Capital Expenditures
-1.7-1.55-0.57-2.8-6.86-1.72
Free Cash Flow
-309.24-266-208.36-156.42-125.5-60.48
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------
Operating Margin
------
Profit Margin
------
FCF Margin
------

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
------